TMEM59 and Alzheimer disease: In summary, our study demonstrates that an elevation of TMEM59 can exacerbate the pathological progress during aging, whereas downregulation of TMEM59 can ameliorate cognitive and synaptic deficits and pathologies in AD model mice.